Table 3.
Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
n | Median survival, months | P-value | HR | 95% CI | P-value | |
Age, years, <60/≥60 | 39/55 | 8/8 | 0.172 | |||
Sex, male/female | 41/53 | 8/8 | 0.525 | |||
Bilirubin, maximum, mg/dl, ≤5/>5 | 77/17 | 8/9 | 0.801 | |||
CEA, ng/ml, ≤5/>5 | 53/37 | 10/7 | <0.001 | 1.849 | 1.109–3.084 | 0.018 |
CA 19-9, U/ml, ≤37/>37 | 35/48 | 8/8 | 0.803 | |||
Stage, IVa/IVb | 16/78 | 8/8 | 0.400 | |||
Distant metastases, +/− | 57/37 | 8/8 | 0.426 | |||
Resection with curative intent, +/− | 16/78 | 16/8 | <0.001 | 2.042 | 1.016–4.101 | 0.045 |
R0 resection, +/− | 15/79 | 16/8 | <0.001 | |||
Adjuvant chemotherapy, +/− | 30/55 | 14/7 | <0.001 | 2.367 | 1.371–4.085 | 0.002 |
Histological grade, G1/G2/G3/G4 | 15/42/25/1 | 8/9/8/33 | 0.462 |
The variables ‘Resection with curative intent’ and ‘R0 resection’ were linearly dependent covariates and their correlation efficient was 0.962 (P < 0.001). In consequence, R0 resection was removed from the multivariate analysis model.
HR, hazard ratio; 95% CI, 95% confidence interval; CEA, carcinoembryonic antigen; CA 19-9, carbohydrate antigen 19-9.